Emily Leproust, Twist

Twist Bio­science plots its 'fac­to­ry of the fu­ture' in Ore­gon, seeks to ex­pand syn­thet­ic DNA client base

One of the lead­ing play­ers at the fore­front of syn­thet­ic DNA pro­duc­tion, Cal­i­for­nia-based Twist Bio­science has al­ready had a busy 2020. Now, seek­ing to ex­pand its client base and tech­nol­o­gy ca­pa­bil­i­ties even fur­ther, it’s build­ing its “fac­to­ry of the fu­ture.”

Twist, which man­u­fac­tures syn­thet­ic DNA by writ­ing it on a sil­i­con chip plat­form, will build a 110,000-square-foot fa­cil­i­ty near Port­land, Ore­gon, that will more than dou­ble its cur­rent pro­duc­tion ca­pac­i­ty by the time the fa­cil­i­ty is op­er­a­tional in 2022.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.